Parnax LAB LTD.
₹108.55▼ -6.45 (-5.61%)
PARNAXLAB·BSE·Healthcare
Market Cap
125.16 Cr
PE Ratio
10.57
Volume
127
Day High - Low
110.70 - 108.35
52W High-Low
149.50 - 104.00
₹108.55▼ -6.45 (-5.61%)
Market Cap125.16 Cr
PE Ratio10.57
Volume127
Day High - Low110.70 - 108.35
52W High-Low149.50 - 104.00
Parnax Lab Ltd. (PARNAXLAB): company summary
Revenue rose 32.4% annually, but the latest quarter revenue rose 6.4% compared to the same quarter a year earlier.
Parnax Lab Ltd. (PARNAXLAB) is a micro-cap Healthcare company valued at ₹125 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Parnax Lab Ltd. last traded at ₹108.55, sharply down 5.61% on the day.
- Recent developments
- On 2026-06-30, the company reported a net profit of ₹0 crore for the latest quarter, down from ₹3 crore in the same quarter a year earlier. The company also reported revenue of ₹57 crore for the latest quarter, up from ₹53 crore in the same quarter a year earlier.
- Financial performance
- Revenue rose 32.4% annually, but the latest quarter revenue rose 6.4% compared to the same quarter a year earlier. Net profit fell 86.9% in the latest quarter compared to the same quarter a year earlier, while annual net profit rose 2.3%.
- Valuation multiples
- The stock trades at 10.6 times earnings, a discount to the Healthcare median of 32.0, 1.59 times book value.
- Things to watch
- Net profit fell 86.9% in the latest quarter compared to the same quarter a year earlier. The company's net profit margin narrowed 1.4 percentage points to 4.7%. The stock is 24.5% below its 52-week high.
- Where it stands
- The company's latest quarter net profit fell 86.9% compared to the same quarter a year earlier, while revenue rose 6.4%. The stock is 24.5% below its 52-week high.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
5.2/10
Weak
Fair Value
Sign in to see
ROE
12.38%
Average
P/E
10.57x
Cheap
Debt / Equity
0.95
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Weak
Price performance
Day₹108.35
₹110.70
52W₹104.00
₹149.50
DocStoX take
Supported by valuation (7.2) and risk (6.7), but held back by momentum (0.0).
DocStoX score
Low confidence5.2
/10
Weak
Quality
Modest
ROE 12.4%
Valuation
Fair
P/E 10.6×
Growth
Steady
Revenue +22.5% 5Y CAGR
Risk
Moderate
D/E 0.95
Momentum
Weak
10% of 52-week range
At a glance
Market Cap
₹125 Cr
52W High / Low
₹150 / ₹104
Dividend Yield
0.00%
Promoter Holding
72.30%
EPS (TTM)
₹10.27
Book Value
₹82.83
Key highlights
- Profitable in all of the last 5 years
- Undemanding at 11× earnings
- Revenue compounding 23% a year
- Momentum is weak (0.0/10)
- Near the bottom of its 52-week range (10%)
3 Positives3 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore PARNAX LAB LTD.’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
PARNAX LAB LTD. peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Related tools & concepts
Value PARNAX LAB LTD. with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing